Weighted-Average Shares Outstanding (Diluted): The number of shares held by shareholders including insiders but not including a company's treasury shares assuming conversion of all convertible debt, securities, warrants and options, sourced from the company 10-K or 10-Q SEC reports.
Neuphoria Therapeutics Inc. (NEUP) had Weighted-Average Shares Outstanding (Diluted) of 1.57M for the most recently reported fiscal quarter, ending 2024-12-31.
| Income Statement Financials | |
$0.66M |
|
$-1.94M |
|
-- |
|
$0.66M |
|
$4.37M |
|
$-3.70M |
|
$1.77M |
|
$-1.93M |
|
$-1.93M |
|
$-1.94M |
|
$-1.94M |
|
$-1.94M |
|
$-1.94M |
|
$-3.70M |
|
$-3.54M |
|
1.57M |
|
|
Weighted-Average Shares Outstanding (Diluted) |
1.57M |
$-1.23 |
|
$-1.23 |
|
| Balance Sheet Financials | |
$4.40M |
|
$0.00M |
|
$13.77M |
|
$18.17M |
|
$2.13M |
|
-- |
|
$2.29M |
|
$4.42M |
|
$13.75M |
|
$0.20M |
|
$13.75M |
|
1.63M |
|
| Cash Flow Statement Financials | |
$-7.79M |
|
-- |
|
$-0.34M |
|
$12.69M |
|
$4.42M |
|
$-8.27M |
|
$0.05M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
2.06 |
|
-- |
|
-- |
|
-- |
|
-- |
|
100.00% |
|
-558.84% |
|
-558.84% |
|
-- |
|
-291.49% |
|
-293.24% |
|
$-7.79M |
|
-- |
|
-- |
|
-- |
|
0.04 |
|
-- |
|
18.64 |
|
4.83 |
|
-14.14% |
|
-949.98% |
|
-10.70% |
|
-14.14% |
|
$8.44 |
|
$-4.95 |
|
$-4.95 |
|